S&P 500
(0.02%) 5 071.63 points
Dow Jones
(-0.11%) 38 461 points
Nasdaq
(0.10%) 15 713 points
Oil
(-0.01%) $82.80
Gas
(0.54%) $1.662
Gold
(-0.38%) $2 329.40
Silver
(-0.48%) $27.22
Platinum
(-0.46%) $911.60
USD/EUR
(0.00%) $0.935
USD/NOK
(0.05%) $10.99
USD/GBP
(0.02%) $0.803
USD/RUB
(-0.94%) $92.32

Realtime updates for Roche Holding AG [RHHBY]

Exchange: OTC Sector: Healthcare Industry: Drug Manufacturersā€”General
Last Updated24 Apr 2024 @ 16:00

-2.24% $ 30.54

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 16:00):

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally...

Stats
Today's Volume 3.14M
Average Volume 2.63M
Market Cap 204.71B
EPS $0.460 ( 2007-02-07 )
Last Dividend $1.287 ( 2023-03-16 )
Next Dividend $0 ( N/A )
P/E 15.58
ATR14 $0.0170 (0.06%)

Volume Correlation

Long: 0.06 (neutral)
Short: -0.62 (weak negative)
Signal:(60.506) Neutral

Roche Holding AG Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Roche Holding AG Correlation - Currency/Commodity

The country flag 0.47
( neutral )
The country flag 0.50
( neutral )
The country flag 0.00
( neutral )
The country flag 0.63
( weak )
The country flag -0.34
( neutral )
The country flag 0.40
( neutral )

Roche Holding AG Financials

Annual 2023
Revenue: $60.44B
Gross Profit: $44.08B (72.94 %)
EPS: $14.39
Q4 2023
Revenue: $28.94B
Gross Profit: $20.66B (71.39 %)
EPS: $5.47
Q2 2023
Revenue: $29.78B
Gross Profit: $22.24B (74.69 %)
EPS: $8.93
Q1 2023
Revenue: $15.31B
Gross Profit: $11.50B (75.11 %)
EPS: $4.44

Financial Reports:

No articles found.

Roche Holding AG Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$1.287
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Roche Holding AG Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 9.81 - good (98.05%) | Divividend Growth Potential Score: 4.23 - Stable (15.49%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.211 2005-02-28
Last Dividend $1.287 2023-03-16
Next Dividend $0 N/A
Payout Date 2023-03-27
Next Payout Date N/A
# dividends 19 --
Total Paid Out $16.76 --
Avg. Dividend % Per Year 0.00% --
Score 2.79 --
Div. Sustainability Score 9.81
Div.Growth Potential Score 4.23
Div. Directional Score 7.02 --
Next Divdend (Est)
(2024-12-31)
$0 Estimate 0.00 %
Dividend Stability
0.05 Very Bad
Dividend Score
2.79
Pay Frequency
Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for OTC

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
NDBKY Ex Dividend Junior 2023-09-07 Annually 0 0.00%
CYFL Ex Dividend Knight 2023-09-05 Quarterly 0 0.00%
TBLMY Ex Dividend Junior 2023-07-06 Annually 0 0.00%
HVRRY Ex Dividend Junior 2023-05-04 Annually 0 0.00%
BDVSY Ex Dividend Junior 2023-09-28 Annually 0 0.00%
PDER Ex Dividend Knight 2023-08-30 Quarterly 0 0.00%
EFGXY Ex Dividend Knight 2023-04-25 Annually 0 0.00%
TXHPF Ex Dividend Knight 2023-12-28 Semi-Annually 0 0.00%
JTEKF Ex Dividend Junior 2023-09-28 Annually 0 0.00%
CBCFF Ex Dividend Junior 2024-03-28 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1941.5006.129.18[0 - 0.5]
returnOnAssetsTTM0.1911.2003.654.37[0 - 0.3]
returnOnEquityTTM0.6181.5004.256.37[0.1 - 1]
payoutRatioTTM0.663-1.0003.37-3.37[0 - 1]
currentRatioTTM1.3470.8008.266.61[1 - 3]
quickRatioTTM1.0260.8008.676.94[0.8 - 2.5]
cashRatioTTM0.2171.5009.9110.00[0.2 - 2]
debtRatioTTM0.340-1.5004.33-6.49[0 - 0.6]
interestCoverageTTM30.481.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM29.532.000.1580.315[0 - 30]
freeCashFlowPerShareTTM21.352.0010.0010.00[0 - 20]
debtEquityRatioTTM1.050-1.5005.80-8.70[0 - 2.5]
grossProfitMarginTTM0.7341.0001.0921.092[0.2 - 0.8]
operatingProfitMarginTTM0.2841.0006.326.32[0.1 - 0.6]
cashFlowToDebtRatioTTM0.7651.0006.866.86[0.2 - 2]
assetTurnoverTTM0.9830.8006.785.42[0.5 - 2]
Total Score9.81

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM1.3201.0009.970[1 - 100]
returnOnEquityTTM0.6182.506.306.37[0.1 - 1.5]
freeCashFlowPerShareTTM21.352.002.8810.00[0 - 30]
dividendYielPercentageTTM4.881.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM29.532.000.1580.315[0 - 30]
payoutRatioTTM0.6631.5003.37-3.37[0 - 1]
pegRatioTTM0.02701.500-3.150[0.5 - 2]
operatingCashFlowSalesRatioTTM0.2651.0005.880[0.1 - 0.5]
Total Score4.23

Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators